Alks 2680 - 搜索图片

640×95
neurologylive.com
Orexin Receptor ALKS 2680 Demonstrates Positive Phase 1 Findings
1920×264
neurologylive.com
Orexin Receptor ALKS 2680 Demonstrates Positive Phase 1 Findings
1250×1250
neurologylive.com
Therapeutic Potential of Orexin Agonist AL…
300×300
neurologylive.com
Therapeutic Potential of Orexin Agonist AL…

465×65
neurologylive.com
Evaluating Positive Phase 1 Trial Data for Narcolepsy Agent ALKS 2680
1280×720
neurologylive.com
Evaluating Positive Phase 1 Trial Data for Narcolepsy Agent ALKS 2680
1142×644
neurologylive.com
Evaluating Positive Phase 1 Trial Data for Narcolepsy Agent ALKS 2680

390×280
shutterstock.com
43 2680 Images, Stock Photos, 3D objects, & Vectors | Shutterstock
960×540
sec.gov
Slide 17
3000×1687
sec.gov
Slide 15

960×540
sec.gov
Slide 5
960×540
sec.gov
Slide 4
960×540
sec.gov
Slide 7

1920×1280
stance-usa.com
RAL_2680 – STANCE SUSPENSION
1496×785
prnewswire.co.uk
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
1200×630
igus.com
2680 series | High strength, quiet, easy assembly
1920×2560
kkool.co.th
IMG_2680 | บริษัท เคคูล โ…

1280×720
sec.gov
Slide 18
1280×720
sec.gov
Slide 16
1434×825
clinicaltrialsarena.com
Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1

3000×1687
sec.gov
Slide 7
3000×1687
sec.gov
Slide 6
3000×1687
sec.gov
Slide 1

3000×1687
sec.gov
Slide 10
3000×1687
sec.gov
Slide 8

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果